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Summary. The adhesion of leukocytes to the endothelium 
of postcapillary venules hallmarks a key event in 
ischemia-reperfusion injury. Adenosine has been shown 
to protect from postischemic reperfusion injury, presum-
ably through inhibition of postischemic leukocyte-endo-
thelial interaction. This study was performed to investi-
gate in vivo by which receptors the effect of adenosine on 
postischemic leukocyte-endothelium interaction is medi-
ated. 
The hamster dorsal skinfold model and fluorescence 
microscopy were used for intravital investigation of red 
cell velocity, vessel diameter, and leukocyte-endothelium 
interaction in postcapillary venules of a thin striated skin 
muscle. l.eukocytes were stained in vivo with acridine or-
ange (0.5 mg kg - 1 nun - 1 i.v. ). Parameters were assessed 
prior to induction of 4 h ischemia to the muscle tissue 
and 0.5 h, 2 h, and 24 h after reperfusion. ·Adenosine, the 
adenosine A 1-selective agonist 2-chloro-N6 -cyclopen-
tyladenosine (CCPA), the Arselective agonist CGS 
21,680, the non-selective adenosine receptor antagonist 
xanthine amine congener {XAC), and the adenosine up-
take blocker S-(p-nitrobenzyl)-6-thioinosine (NBTI) were 
infused viajugular vein starting 15 min priortorelease of 
ischemia until 0.5 h after reperfusion. 
Adenosine and CGS 21,6f~ significantly reduced 
postischemic leukocyte-endothelium interaction 0.5 h af-
ter reperfusion (p< 0.01), while no inhibitory effect was 
observed with CCPA. Coadministration of XAC blocked 
the inhibitory effects of adenosine. Infusion of NBTI 
alone effectively decreased postischemic leukocyte-endo-
thelium interaction. 
These findings indicate that adenosine reduces post-
ischemic leukocyte-endothelium interaction via A2 recep-
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tor and suggest a protective role of endogenous adeno-
sine during ischemia-reperfusion. 
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lntroduction 
Ischemia and ensuing reperfusion are associated with the 
activation of leukocytes which first roll and then become 
stuck to the microvascular endothelium via upregulation 
of specific adhesion receptors. Through the release of 
cytotoxic enzymes and formation of oxygen free radicals, 
sticking leukocytes contribute to postischemic reperfu-
sion injury, as characterized by enhanced microvascular 
leakage (Lehret al. 1991; Menger et al. 1988; Nolte et al. 
1991 a), and decrease of nutritional blood flow due to en-
dothelial swelling (Mazzoni et al. 1989). In keeping with 
this concept, therapeutic inhibition of postischemic leu-
kocyte-endothelium interaction by monoclonal antibod-
ies directed against leukocyte adhesion receptors (Arfors 
et al. 1987) or by leukocyte depletion using anti-neutro-
phil serum (Hernandez et al. 1987) effectively reduces the 
extent of reperfusion injury. 
Adenosine has been shown to reduce postischemic 
reperfusion injury in different organ systems (Grisham et 
al. 1989; Dux et al. 1990). These effects of adenosine have 
been ascribed to its vasodilatory action (Berne 1980) as 
well as to its potential to decrease leukocyte activation 
(Cronstein et al. 1986), presumably via activation of the 
cyclic AMP pathway (Iannone et al. 1987; Omann et al. 
1987). 
Most of the physiological effects of adenosine are me- · 
diated through membrane bound receptors, the A1 (Ri) 
subtype and the A2 (RJ subtype (Londos et al. 1980), 
both of which are expressedonhuman leukocyte mem-
branes (Marone et al. 1985). There is evidence that activa-
tion of the adenosine A2 receptor is followed by de-
creased leukocyte responsiveness to stimulation as as-
· sessed by superoxide radical formation (Cronstein et al. 
1985), release of H20 2, myelopero:xidase and cytotoxic 
enzymes (Riches et al. 1985; Iannone et al. 1987), adhe-
sion of stimulated leukocytes to cultured endothelial cells 
and leukocyte-induced endothelial darnage (Cronstein et 
al. 1986). 
Using the dorsal skinfold chamber model for in-
travital microscopy in awake hamsters, we have recently 
demonstrated that adenosine reduces postischemic 
leukocyte-endothelium interaction in striated muscle tis-
sue in vivo (Nolte et al. 1991 b). Although numerous in 
vitro data suggest the involvement of an A2 receptor-me-
diated mechanism for this inhibitory action of adenosine 
on postischemic leukocyte-endothelial interaction, to 
date no study has been performed to investigate the role 
of adenosine receptor subtypes under postischemic con-
ditions in vivo. 
Materials and methods 
Materials. Adenosine, acridine orange, and S-(p-nitrobenzyl)-6-
thioinosine (NBTI) were purchased from Sigma Chemical Co., 
Deisenhofen, FRG. Pentabarbital-Natrium was from Sanofi/CEVA, 
Hannover, FRG. 2-chloro-6-aminocyclopentyladenosine (CCPA) and 
xanthine amine congener (XAC) were kindly provided by Prof. Dr. U. 
Schwabe, Institute of Pharmacology, University of Heidelberg, FRG. 
2-(p-(2-carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamido-adeno-
sine (CGS 21,680) was a gift from Dr. M. F. Jarvis, Summit, N.J., USA. 
Anima/ model. Experiments were carried out in the dorsal skinfold 
chamber model of the Syrian golden bamster (60-80 g, 6-8 weeks of 
age). This preparation allows intravital microscopic investigation of tbe 
microcirculation in striated muscle and skin in conscious animals. Dor-
sal skinfold chambers and permanent venous and arterial catheters were 
implanted in 36 animals as described previously in detail (Endrich et al. 
1980). Under pentobarbital anesthesia (SO mg kg- 1 body weight i.p.), 
animals were surgically fitted with 2 symmetric titanium frames posi-
tioned on the dorsal skinfold, in such a fashion that they sandwiched 
the extended skinfold. A circular 15 mm diameter area of one of the lay-
ers was completely removed and the remaining layer, containing striated 
muscle and subcutaneous tissue, was covered with a removable cover 
glass incorporated into one of the frames. Fine polyethylene catheters 
were passed subcutaneously from the dorsal to the ventral side of the 
neck and placed into jugular vein and carotid artery. A recovery period 
of 48 h was allowed between the chamber implantation and the micro-
scopic investigations in order to eliminate side effects of anesthesia and 
surgical trauma on the microcirculation. 
Ischemia for 4 h was induced to the striated muscle contained within 
the Observation window by means of an adjustable screw clamp equip-
ped with a transparent silicone pad (Sack et al. 1987; Menger et al. 
1988). The tissue in the chamber was observed by transillumination 
while the pad was gently pressed form the posterior side onto the tissue 
until blood supply to the tissue was completely stopped. 
Intravital f/uorescence microscopy. Four to six postcapillary venules 
(20- 60 J.I.ID in diameter) were investigated in each animal. Vessel seg-
ments of 200 J.l.m length were examined at predetermined intervals using 
a stepping motor-driven platform that allows the computerized relocali-
zation of previously defined vessel segments. Vessel diameters and leu-
kocyte-endothelium interaction were examined by intravital fluores-
cence microscopy (magnification 560x). Intravital microscopic pictures 
were recorded on videotape and evaluated offline, using the computer-
assisted microcirculation analysis system (CAMAS, Zeintlet al. 1989). 
For visualization of leukocytes, 0.1 m1 of the fluorescent marker 
acridine orange was infused intravenously during the microscopic inves-
tigations (0.5 mg kg -I min- 1 ). Bach leukocyte was assigned an adhe-
sion coefficient (AC), calculated from the velocity of each leukocyte 
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(WBCV) and the velocity of the surrounding red cell column (RBCV) 
as AC = (RBCV-WBCV)/RBCV. This ratio differentiates free-flowing 
leukocytes (O<AC<0.8), rolling leukocytes (0.8sAC< 1.0) and stick-
ing leukocytes (AC = 1.0). As shown in a validation experiment, this ap-
proach yields reproducible results (Zeintl et al. 1989). Sticking leuko-
cytes were expressed as number of cells per mm2 of endothelial surface 
that did not move or detacb from the endotheliallining within the entire 
observation period of 1 minute, calculated from diameter and length 
(200 J.I.ID) of the vessel segment under investigation. Rolling leukocytes 
were expressedas percentage of nonadherent leukocytes ( = free-flow-
ing+rolling leukocytes) passing through the observed vessel segment 
within one minute. RBCV measurements were performed with a photo-
metric analyzer and the dual slit tecbnique (Velocity tracker Model 
102 B, I.P.M., San Diego, Calif.; USA). 
Experimental protocol. Animals were randomly assigned to control or 
test groups. Baseline values for leukocyte-endothelium interaction, 
RBCV, and vessel diameters were assessed prior to induction of 4 h 
ischemia. The same parameters were measured in the identical vessel 
segments 0.5 h, 2 h, and 24 h after reperfusion. During the experiment 
the ambient temperature of the experimental system and infusions were 
maintained at room temperature. 
The following drugs were infused intravenously at an infusion rate 
of 0.18 ml h-t starting 15 min priortorelease of ischemia and contin-
ued until 0.5 h after reperfusion: a) 10 mmoll- 1 adenosine, b) 0.1 J.l.mol 
1-1 CCPA, c) 10 J.I.IDOll- 1 CGS 21,680, d) 10 mmoll- 1 adenosine 
+0.7 J.I.IDOll- 1 XAC and e) 0.24 J.1.mol1-t NBTI. Control animals re-
ceived equivalent volumes of isotonic saline. In each experimental group 
(n = 6 animals), blood pressure and heart rate were continuously moni-
tared via an indwelling catheter in the carotid artery. The described drug 
concentrations were chosen following the criterion that blood pressure 
and heart rate were not affected in order to rule out alterations of the 
macrohemodynamic flow conditions. In order to rule out side effects of 
DMSO (Hameroff et al. 1983), which has been used as solvent for 
CCPA and NBTI, six animals were infused with DMSO doses equiva-
lent to the content in the NBTI solution. No effects of this solvent on 
macrocirculatory parameters (blood pressure and heart rate) or leuko-
cyte-endothelium interaction were observed as compared to saline-treat-
ed control animals. 
Statistic. Statistical tests were performed only on experiments where 
measurements at all time points of investigation were complete. For Iack 
of parametric distribution, Wilcoxon test was used to test for significant 
differences between the groups (SAS® Version 5, 1989, SAS Institute 
Cary, N.C., USA). Differences were considered significant at p<0.05 
and depicted in the figures. Values in figures and tables are given as 
mean ± SD of six anirnals investigated per experimental group. 
Results 
During performance of the experiments the macrohemo-
dynamic parameters blood pressure and heart rate as weil 
as the microhemodynamic parameters vessel diameter 
and red cell velocity were not affected by the administra-
tion of the drugs as compared tö the saline-treated con-
trols (data not shown). 
Effects of adenosine, CCPA, CGS 21,680, XAC: and 
NBTI on posfischernie /eukocyte-endothelium interaction 
A 4 h ischemia and ensuing reperfusion elicited a drastic 
enhancement of both postischemic leukocyte sticking to 
and rolling of leukocytes along the endothelial lining of 
postcapillary venules in striated skin muscle of the ham-
ster. The application of adenosine ( 10 mmoll- 1) during 
the early reperfusion period significantly attenuated this 
increase of the number of sticking leukocytes (Fig. 1). In-
fusion of the adenosine A1-selective agonist CCPA had 
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no inhibitory effeet on pastisehernie leukocyte stieking. 
In eontrast, 24 h after reperfusion an approximately 
three-fold inerease of the number of stieking leukoeytes 
was observed as eompared to eontrols while infusian of 
the Arselective agonist CGS 21,680 resulted in a potent 
reduetion of pastisehernie leukocyte stieking as found un-
der treatment with adenosine (Fig. 1). Simultaneaus infu-
sion of adenosine with XAC resulted in eomplete abroga-
tion of the adenosine-indueed effeets on pastisehernie 
leukocyte stieking. Infusion of NBTI alone effectively re-
duced leukocyte sticking until 0.5 h after reperfusion. 
Pastischemie leukocyte rolling was significantly re-
dueed by adenosine, CGS 21,680, and NBTI after 0.5 h 
reperfusion as eompared to the saline-treated controls 
while no inhibitory effeets were observed when animals 
were treated with CCPA or a simultaneaus infusian af 
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Fig.l. Effects of adenosine, CCPA, CGS 21,680, XAC, and NBTI on 
postischemic leukocyte sticking and rol1ing in striated muscle of the 
hamster. A 4 h ischemia was induced to a thin striated skin muscle of 
the hamster. Leukocyte-endothelium interaction was assessed in 4-6 
postcapillary venules {20-60 J.I.ID diameter) before ischemia and at pre-
determined intervals after reperfusion using CAMAS. Sticking leuko-
cytes (AC= 1) were defined as cells that did not move or detach from 
the endothelial lining within the entire Observation time of 1 min and 
given as cells per mm2 endothelial surface. Rolling leukocytes were de-
fined as cells with 0.8 s AC< 1 and given in percentage of nonadherent 
leukocytes passing the vessel segment. Drugs were infused 15 min prior 
to release of ischemia until 0.5 h after reperfusion at 0.18 ml h -t. Con-
trol animals received equivalent volumes of isotonic saline. Values are 
means±SD of 6 animals investigated per experimental group. 
* p < 0.05, ** p < 0.01 vs. saline, Wilcoxon test 
Discussion 
Sturlies from our Iabaratory suggest that the beneficial 
effeets af adenosine on ischemia-reperfusian injury are 
due to its inhibitory aetian on postisehemic leukocyte-en-
dothelium interactian (Nalte et al. 1991 b). The demon-
stration in this manuseript that the effects of adenasine 
can be mirnicked by infusion of the adenosine Arselec-
tive agonist CGS 21680 (Jarvis et al. 1989) but not by the 
A1-selective agonist CCPA (Lohse et al. 1988), and ean 
be blocked by the non-seleetive antaganist XAC, suggests 
that the effects of adenosine are mediated via the adeno-
sine A2 reeeptor. 
The abrogation of the adenasine effeets by XAC indi-
cates the involvement of these extracellular reeeptors. Ac-
tivatian of the A2 reeeptor results in stimulation af ade-
nylate cyclase (Londos et al. 1980). This results in an in-
erease of intraeellular cyclic AMP eoneentration which 
has been shown to eaunteraet leukoeyte aetivation 
(Omann et al. 1987), presumably through the inhibition 
af the leukacyte-aetivating phospholipase C pathway 
(Thitelbaum 1990). On the other hand, the Iack in aur ex-
periments of inhibitary effects on leukocyte-endothelium 
interaetion by treatment with the A1-seleeti ve agonist 
CCPA, along with the finding of an enhanced leukocyte 
sticking 24 h after reperfusion, paints to a facilitatian af 
pastisehernie leukocyte aetivation via the At receptor. We 
therefore suggest a dual action of adenasine on past-
isehernie leukocyte-endothelium interaetion with At re-
ceptor Stimulation resulting in enhancement, while A2 
reeeptor aetivation resulting in reduetion of pastisehernie 
leukoeyte-endothelium interaction. Furthermore, the 
finding that the uptake inhibitar NBTI was also effeetive 
to deerease leukacyte-endathelium interaction, suggests a 
pratective role far endogenaus adenosine during ischemia-
reperfusion. 
Before leukocytes ean emigrate towards the inflamma-
tory focus, they have to marginate in order to start rolling 
whieh is achieved by non-firm interaction with the miero-
vaseular endothelium, mediated through expression of 
specifie adhesion reeeptors of the selectin family (Law-
rence and Springer 1991). For the emigration process, 
firm adhesion of leukocytes to the mierovascular endo-
thelium is required and considered as the seeond step af-
ter leukocyte rolling (Von Andrian et al. 1991). Therefore, 
aur results may be interpreted as an action of adenosine 
on pastisehernie leukacyte rolling alone and/or leukocyte 
sticking. 
There is evidence that ehanges of the intracellular cy-
clic AMP concentration by adenosine affect the expres-
sian of membrane-embedded reeeptors such as CD 4, 
CD 8, and Fe" reeeptors on T-lymphocytes, accounting 
for its immunaregulatory funetion (Birch and Polmar 
1986). Likewise, it has reeently been reported that the rise 
of the intraeellular cyelie AMP coneentration by 
2-chlaro-adenosine inhibits matility and adhesion recep-
tor dustering of human umbilical vein endathelial cells 
(Lampugnani et al. 1990).· Therefore, it is intriguing ta as-
sume that in respanse to the adenasine-induced trans-
membrane signal the expressian of adhesian reeeptors ei-
ther on leukacyte anci/or endothelium is affected. Shear 
force-dependent alterations of leukocyte-endothelium in-
teraction by infusion of the drugs can be ruled out since 
neither changes of blood pressure and heart rate nor 
changes of the microhemodynamic parameters vessel di-
ameter and red cell velocity have been observed under the 
given drug doses. 
This study provides first in vivo evidence that an A2 
receptor-dependent mechanism mediates the effects of 
adenosine on pastisehernie leukocyte-endothelium inter-
action. The finding that inhibiton of adenosine uptake 
alone has the potential to reduce leukocyte rolling and 
sticking points to a pathophysiologic role of endogenous 
adenosine in this event. However, it still remains to be in-
vestigated whether the effects of adenosine are secondary 
to the modulation of the release of inflammatory media-
tors which are known to affect leukocyte-endothelium in-
teraction, or a direct effect on the expression of adhesion 
receptors on leukocyte and/or endothelium. 
Aclcnowledgements. We are grateful to Prof. Dr. U. Schwabe, Phar-
makologisches Institut·der Universität Heidelberg, Germany, for help-
ful discussions during performance of the experiments. This study was 
supported by Sonderforschungsbereich 320. 
References 
Arfors KE, Lundberg C, Lindborn L, Lundberg K, Beatty BG, Harlan 
JM (1987) A monoclonal antibody to the membrane glycoprotein 
complex CD 18 inhibits polymorphonuclear leukocyte accumulation 
and plasma leakage in vivo. Blood 69:338- 340 
Beme RM (1980) The role of adenosinein the regulation of coronary 
blood flow. Circ Res 47:807-813 
Birch RE, Polmac SH (1986) Adenosine-induced immunosuppression: 
the role of the adenosine receptor-adenylate cyclase interaction in 
the alteration of T-lymphocyte surface phenotype and im-
munoregulatory function. Int J Immunopharmacol 8:329-337 
Cronstein BN, Rosenstein ED, Kram er SB, Weissmann G, Hirschhorn 
R (1985) Adenosine: a physiologic modulator of supermeide anion 
generation by human neutrophils. Adenosine acts via an A2-recep-
tor on human neutrophils. J Immunol 135:1366-1371 
Cronstein BN, Levin Rl, Belanoff J, Weissmann G, Hirschhorn R 
{1986) Adenosine: an endogenaus inhibitor of neutrophil-mediated 
injury to endothelial cells. J Clin Invest 78:760-770 
Dux E, Fastborn J, Ungerstedt U, Rudolphi K, Fredholm BB {1990) Pro-
teelive effect of adenosine and a novel xanthine derivative propen-
tofylline on the cell darnage after bilateral carotid occlusion in the 
gerbil hippocampus. Brain Res 516:248-256 
Endrieb B, Asaishi K, Götz A, Messmer K {1980) Technical report -
a new chamber technique for microvascular studies in unanesthetiz-
ed hamsters. Res Exp Med 177:125-134 
Grisham MB, Hemandez LA, Granger DN (1989) Adenosine inhibits 
ischemia/reperfusion-induced leukocyte adherence and extravasa-
tion. Am J Physiol 257:H 1334- H 1339 
Hameroff SR, Otto CW, Kanel J, Weinstein PR, Blitt CD {1983) Acute 
eardiovascular effects of dimethyl sulfoxide. Ann NY Acad Sei 
411:94-99 
237 
Hemandez LA, Grisham MB, Twohing B, Arfors K-E, Harlan JM, 
Granger DN (1987) Role of neutrophils in isehemia-reperfusion-in-
duced microvaseular injury. Am J Physiol253:H699-H703 
Iannone MA, Zimmermann TP, Reynolds-Vaughn R, Wolberg G (1987) 
Effects of adenosine on human neutrophil function and cAMP con-
tent. In: Gerlach E, Beeker BF (eds) Thpics and perspeetives in aden· 
osine research. Springer, Berlin Heidelberg New York, pp 286-299 
Jarvis MF, Schulz R, Hutebison AJ, Do UH, Sills MA, Williams M 
(1989) [H3]CGS-21,680, a selective A2 adenosine reeeptor agonist 
directly Iabels A2 receptors in rat brain. J Pharmacol Exp Ther 
251 :888- 893 
Lampugn"ani MG, Giorgi M, Gaboll M, Dejana E, Marchisio PC (1990) 
Endothelial cell motility, integrin reeeptor clustering, and microfila-
ment organization are inhibited by agents that inerease cAMP. Lab 
Invest 63:521-531 
Lawrence MB, Springer TA {1991) Leukocytes roll on a selectin at physi· 
ologie flow rates: distinction from and prerequiste for adhesion 
through integrins. Cell 65:859-873 
Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K (1991) 
Leukotrienes as mediators in ischemia-reperfusion injury in a 
microcireulation model of the hamster. J Clin Invest 87:2036-2041 
Lohse MJ, Klotz K-N, Schwabe U, Cristalli G, Vittori S, Grifantini M 
(1988) 2·Chloro-W-cyclopentyladenosine: a highly selective agonist 
at A1 adenosine reeeptors. Naunyn-Schmiedeberg's Arch Phar-
macol 337:687-689 
Londos C, Cooper DMF, Wolff J (1980) Subdasses of external adeno-
sine receptors. Proc Natl Acad Sei USA 77:2551-2554 
Marone G, Petracca R, Vigorita S (1985) Adenosine receptors on hu-
man inflammatory cells. Int Arch Allergy Appl Immunol 
77:259-263 
Mazzoni MC, Borgström P, lntaglietta M, Arfors K-E {1989) lAlmenal 
narrowing and endothelial cell swelling in skeletal muscle capillaries 
during hemorrhagic shock. Circ Shock 29:27- 39 
Menger MD, Sack F-U, Barker JH, Feifel G, Messmer K (1988) Quimti-
tative analysis of microcirculatory disorders after prolonged 
ischemia in skeletal muscle. Therapeutic effects of propbylactic 
isovolemic hemodilution. Res Exp Med 188:151-165 
Nolte D, Lehr HA, Sack F-U, Messmer K (1991 a) Reduction of 
pastisehernie reperfusion injury by the vasoactive drug buflomedil. 
Blood Vessels 28:8-14 
Nolte D, Lehr HA, Messmer K (1991 b) Adenosine inhibits postischemic 
leukocyte-endothelium interaction in postcapillary venules of the 
hamster. Am J Physiol 261:H651-H655 
Omann GM, Allen RA, Bokoch GM, Painter RG, '"fraynor AE, Sklar 
LA (1987) Signal transduction and cytoskeletal activation in the 
neutrophil. Physiol Rev 67:285-322 
Riches DWH, Watkins JL, Henson PM, Stanworth PR (1985) Regula-
tion of macrophage lysosomal secretion by adenosine, adenosine 
phosphate esters, and related stuctural analogues of adenoslne. J 
Leuk Biol 37:545-557 
Sack F-U, Funk W, Hammersen F, Messmer K (1987) Mierovascular in-
jury of skeletal muscle and skin after different periods of pressure 
induced ischemia. Prog Appl Microcirc 12:282-288 
Thitelbaum I (1990) Cyclic adenosine monophosphate and diacylgly-
cerol: mutually inhibitory second messengers in cultured rat inner 
medullary collecting duct cells. J Clin Invest 86:46-51 
Von Andrian UH, Chambers JD, MeEvoy LM, Bargatze RF, Arfors K-
E, Butcher EC (1991) 1\vo step model of leukocyte-endothelial eell 
interaction in inflammation: distinct roles for LECAM-1 and the 
leukocyte P2 integrins in vivo. Proc Natl Acad Sei USA 
88:7538-7542 
Zeintl H, Sack F-U, Intaglietta M, Messmer K (1989) Computer assisted 
leukocyte velocity measurement in intravital microscopy. Int J 
Mierocirc Clin Exp 8:293- 302 
